The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

But a new proposal announced by the Biden administration in November ... But it also comes with a price tag in the tens of ...

Building on the success of the anti-Myostatin program, iBio Launches New Program Featuring Myostatin + Activin A Bispecific ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity ... chipped away the obesity rate: sales of weight-loss medications soared, new paths to getting the ...

But in the recent past, novel anti-obesity drugs have made the kind ... you will not beat the new obesity drugs. What does this mean to those struggling with obesity? Dietary modifications and ...

We believe that over the next 5–10 years new anti-obesity drugs with less adverse side-effects and favorable effects on both lipids and cardiometabolic risk will be introduced in clinical practice.

Only 13 states currently offer Medicaid coverage for these drugs. The new proposal would change this by requiring Medicaid to cover anti-obesity drugs and allowing Medicare to do so for those with ...